Ken Griffin
VCNX

Ken Griffin’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Ken Griffin’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-491
Closed -$36.7K – 15325
2023
Q2 		$36.7K Buy
491
+327
+199% +$27.2K ﹤0.01% 12142
2023
Q1 		$13.8K Buy
164
+128
+356% +$14.1K ﹤0.01% 13346
2022
Q4 		$5K Sell
36
-441
-92% -$54.7K ﹤0.01% 14042
2022
Q3 		$50K Buy
477
+201
+73% +$39.5K ﹤0.01% 11632
2022
Q2 		$63K Sell
276
-47
-15% -$12K ﹤0.01% 11783
2022
Q1 		$90K Sell
323
-65
-17% -$18K ﹤0.01% 12385
2021
Q4 		$86K Buy
+388
New +$140K ﹤0.01% 12865
2021
Q3 		– Sell
-74
Closed -$36.9K – 14846
2021
Q2 		$43K Sell
74
-230
-76% -$122K ﹤0.01% 13394
2021
Q1 		$190K Buy
304
+137
+82% +$88.1K ﹤0.01% 11765
2020
Q4 		$73K Sell
167
-52
-24% -$21.8K ﹤0.01% 10397
2020
Q3 		$82K Buy
+219
New +$239K ﹤0.01% 9381

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Ken Griffin's VCNX Position: Q3 2023 in Review

Ken Griffin sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2023, closing a stake of 491 shares — an estimated $36.7K sold.

Ken Griffin first reported a position in VCNX in Q3 2020 and held it in 11 quarters. The position peaked at $190K in Q1 2021. 18 funds tracked by Wall St. Rank hold VCNX as of Q3 2023.

  • Ken Griffin reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ken Griffin sold 491 Vaccinex, Inc. Common Stock shares in Q3 2023, an estimated $36.7K.
  • Ken Griffin first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Ken Griffin's Vaccinex, Inc. Common Stock position peaked at $190K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.